LXRX Q3 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23,000-99.7% YoY

Gross Profit

$23,000100.0% margin

Operating Income

-$23M-99834.8% margin

Net Income

-$23M-100530.4% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-90.2%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$172M

Total Liabilities

$36M

Stockholders' Equity

$137M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23,000	$7M	-99.7%
Gross Profit	$23,000	$6M	-99.6%
Operating Income	-$23M	$87M	-126.5%
Net Income	-$23M	$83M	-128.0%